Glucose Dependent Insulinotropic Polypeptide and Glucagon Like Peptide 1 in Medicine Encyclopedia MDPI Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Glucagon like peptide 1 (GLP 1) receptor agonists are incretin analogues that promote glucose mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP 1 receptor agonists and GLP 1 and glucose dependent insulinotropic Efficacy and safety of incretin co agonists: Transformative advances in cardiometabolic healthcare Efficacy and safety of incretin co agonists: Transformative advances in cardiometabolic healthcare Medicating Appetite: What Ozempic, Wegovy, and Other GLP 1 Drugs Really Mean